International Biotechnology (LON:IBT) Insider Katherine Cornish-Bowden Buys 1,500 Shares

International Biotechnology (LON:IBT) insider Katherine Cornish-Bowden purchased 1,500 shares of the business’s stock in a transaction dated Tuesday, December 17th. The shares were purchased at an average cost of GBX 713 ($9.06) per share, for a total transaction of £10,695 ($13,596.49).

International Biotechnology Stock Performance

International Biotechnology stock opened at GBX 698 ($8.87) on Wednesday. The business has a 50 day moving average of GBX 694.15 and a 200-day moving average of GBX 677.59. The company has a debt-to-equity ratio of 9.66, a current ratio of 0.46 and a quick ratio of 0.32. International Biotechnology has a 1 year low of GBX 588 ($7.48) and a 1 year high of GBX 734 ($9.33). The company has a market capitalization of £257.98 million, a P/E ratio of 1,454.17 and a beta of 0.21.

International Biotechnology Increases Dividend

The firm also recently declared a dividend, which will be paid on Friday, January 24th. Shareholders of record on Thursday, December 19th will be given a GBX 15.56 ($0.20) dividend. This is a boost from International Biotechnology’s previous dividend of $14.50. This represents a yield of 2.21%. The ex-dividend date is Thursday, December 19th. International Biotechnology’s dividend payout ratio is 6,041.67%.

International Biotechnology Company Profile

International Biotechnology Trust plc specializes in investments in development stage and late stage companies. The majority of the fund's assets are generally invested in smaller and mid-capitalization quoted companies, with a minority in larger capitalization quoted companies. It makes long only investments.